Primary Cutaneous <scp>NK</scp> /T‐Cell Lymphoma With Aberrant <scp>CD20</scp> Expression Responsive to <scp>SMILE</scp> Chemotherapy
The authors declare no conflicts of interest. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Authors
- I. Gassara (ORCID: https://orcid.org/0009-0000-9856-2981)
- R. Chaabouni (ORCID: https://orcid.org/0000-0002-0021-6704)
- Khadija Sellami (ORCID: https://orcid.org/0000-0002-1565-9663)
- Nour Siala (ORCID: https://orcid.org/0009-0003-2025-0525)
- H. Turki (ORCID: https://orcid.org/0000-0003-0167-6718)
- Slim Charfi (ORCID: https://orcid.org/0000-0001-8497-9815)
- Faten Kallel
- Tahya Sellami Boudawara
- Moez Elloumi
- Malek Cherif (ORCID: https://orcid.org/0009-0003-1087-2961)
- Fatma Bouaziz
Institutions
- Hopital Universitaire Hedi Chaker (TN)
- Hopital Universitaire Habib Bourguiba (TN)
Publication Details
- Journal
- Journal of Cutaneous Pathology
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1111/cup.70017
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 0.00